SMTL ID : 9gip.1

BFL1 covalently bound to inhibitor compound 7

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.46 Å

Oligo State

monomer

Ligands

1 x 01: ~{N}-[4-[(1~{R},3~{R})-3-azanylcyclopentyl]oxyphenyl]-~{N}-[(1~{S})-1-(4-chlorophenyl)ethyl]propanamide

01.1: 11 residues within 4Å: Chain A: L.53, C.56, L.57, V.60, L.71, Q.74, V.75, E.79, F.96, I.99, L.100 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.53, A:L.57, A:V.60, A:L.71, A:Q.74, A:V.75, A:V.75, A:V.75, A:F.96 Hydrogen bonds: A:E.79

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Palisse, A. et al., Structure-Based Discovery of a Series of Covalent, Orally Bioavailable, and Selective BFL1 Inhibitors. J.Med.Chem. (2024)

Release Date

2024-12-18

Peptides

Bcl-2-related protein A1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Bcl-2-related protein A1

Related Entries With Identical Sequence